Throughout the world, infection followed by sepsis is responsible for 50–60% mortalities among burn patients. In case of developing countries, it is estimated that 75% burn mortalities are due to sepsis. It is reported that overcrowding, lack of essential elements for optimal burn care and delayed presentation of patients are among the common factors for increased burn related complications and mortalities in developing countries [20]. Studies undertaken in the 1950s through 1990 have contributed a lot for our current understanding on the epidemiology of burn wound infections and associated complications. That era was characterized by burn care practices of delayed excision of burn eschar and limited use of topical antibiotics. Consequently, it has been reported that the overall morbidity and mortality following burn wound infections, tissue invasion, and secondary sepsis were extremely high, with case fatality rate of 40% and above following severe burn injury [21–22].
According to the result of our study a total of 46 patients (61.3%) developed complications before and/or while being treated at our burn unit. These included wound infection, graft loss, sepsis, acute kidney injury, malnutrition, pressure ulcer, and limb compartment syndrome. Burn wound infection was the commonest complication identified among the study, occurring in 31 (41.3%) of patients. Of these patients who developed complications, some had more than one complication occurring concurrently.
There are multiple factors which play major roles on impacting the final outcome of burn wound infections and associated complications. These factors include patient demographics, burn severity, obesity, diabetes, immunosuppression; and use of topical antibiotics, early excision and infection prevention measures taken in the burn’s unit. A number of research reports from various centers indicate that the very young and the very old members of the population have an increased risk of developing a worse clinical outcome following burn injury than patients in other age groups [23–25].
The presence of significant percentage of young patients in our study indicates that, our study population were most likely to develop a worse clinical outcome following burn injury. In addition, majority (n = 39, 52%) of the patients had a TBSA burn between 20% and 30%, while nine (11.8%) of the patients had TBSA burn greater than 30%. These findings indicate that there were multiple risk factors among our study population, which could lead to a number of severe burn complications.
Among victims of severe burn injury there will be destruction of skin, which result in loss of its barrier function. After enduring sterile for the first 48hrs following injury, burn wounds will eventually become colonized with various microorganisms [26–28]. Gram-positive bacteria which reside deep in the skin adnexa are the first to heavily colonize the wound surface. Then after an average of 5 to 7 days burn wounds will further become colonized with other microbes, which includes gram-positive bacteria, gram-negative bacteria, and yeasts derived from the host's normal gastrointestinal and upper respiratory flora. Additionally, colonization of burn wound could result due to transfer of nosocomial microbes from the hospital environment [29]. Introduction of penicillin during the 1950s resulted in significant reduction of Streptococcus pyogenes caused burn wound infection among the severely burned patients. Consequently, Staphylococcus aureus became the principal etiological agent of burn wound infections in the decades following 1950s. In addition, the decades following the introduction of antibiotics is marked by a gradual increment in identification of less common microbes as a cause for burn wound infection which includes other gram-positive and gram-negative bacteria, anaerobic bacteria, fungi, and viruses [30–32].
In our study, Pseudomonas aeruginosa was found to be the commonest isolate followed by Staphylococcus aureus, Klebsiella pneumoniae, Aspergillus, and Kingella kingae. In addition, we identified more monomicrobial positive swabs than polymicrobial. These findings of our study are comparable with reports of a number of other studies held in other centers [33–38].
Now a days effective treatment of burn wound infection is being severely challenged due to the emergence antimicrobial resistant pathogens causing burn wound infections [36]. The presence of nosocomial isolates which include MRSA, methicillin-resistant coagulase-negative staphylococci, vancomycin-resistant enterococci, and multiply resistant gram-negative bacteria that possess several types of beta-lactamases, including extended-spectrum beta-lactamases, ampC beta-lactamases, and metallo-beta-lactamases, in burn centers have resulted in the occurrence of invasive and life-threatening infections among hospitalized burn patients [37]. Additionally amplified use of broad spectrum topical and systemic antibiotics for the treatment of burn infections resulted in increased identification of opportunistic pathogens, particularly Candida spp. which have showed increasing degrees of antifungal drug resistance [38].
Based on the study conducted in a burn treatment facility in Bangladesh, Pseudomonas aeruginosa isolates were found to be moderately resistant to ciprofloxacin (52.17%), and to Amikacin (39.83%), but with higher resistance to other antimicrobials, which include Doxycycline (78.3%), tetracycline (65.57%), and Gentamicin (53.6%). Investigators of the study have also reported that Staphylococcus aureus have showed strikingly higher resistant to Amikacin, and Gentamicin (100%); but a moderate resistance to Doxycycline (72%), Oxacillin (78.8%) and Tetracycline (87.7%) and a reduced resistance to Chloramphenicol (23.57%) and Ciprofloxacin (39.66%). Similarly, Klebsiella spp. were found to be resistant to all of the antibiotics used in the study except for Ciprofloxacin where it showed a 100% sensitivity [37]. Another prospective study was conducted in a burn treatment facility in Saudi Arabiya, which showed that Staphylococcus aureus was resistant to 15 different antibiotics but fully sensitive to oxacillin, vancomycin, and ampicillin/sulbactam. [38]
The findings of our study are comparable to the above-mentioned findings in other centers, where we found Pseudomonas aeruginosa to be highly sensitive to Meropenem, Tobramycin, Gentamycin, and Ciprofloxacillin, while it showed high resistance to ceftriaxone and ceftazidime, Cotrimoxazole, Amoxicillin-clavulanic acid. Similarly, the sensitivity pattern of Staphylococcus aureus at our burn center was found to be similar to the other centers, where we found it to be sensitive to vancomycin, tetracycline, meropenem, and linezolid, while it showed resistance to erythromycin, clindamycin, penicillin, cotrimoxazole, Ciprofloxacillin, gentamycin, ampicillin, amoxicillin-clavulanic acid, and oxacillin. Additionally, based on the findings of our study Klebsiella pneumoniae was found to be resistance to most of the tested antibiotics (Ciprofloxacillin, cotrimoxazole, gentamycin, clindamycin, ampicillin, amoxicillin-clavulanic acid and oxacillin) except for meropenem, tetracycline, and linezolid. Therefore, findings of our study and its comparison against results from other centers indicates that, there is a comparable antibiotic sensitivity and resistance pattern at out burn unit.
In conclusion, Pseudomonas Aeruginosa is found to be the most common bacteria isolate from the wounds of our study participants and it is found to be sensitive to Meropenem, Tobramycin, Gentamycin and Ciprofloxacillin; but resistant to Ceftriaxone and Ceftazidime. Based on the findings of our study we recommend that, standard treatments of burn wound infections and associated sepsis should target the common bacterial isolates according to their antibiotic sensitivity pattern. In addition, we recommend a large-scale study to be conducted in the unit, to identify the common microbial residual sites, contamination points and to further characterize the common bacterial isolates.